Literature DB >> 22284189

Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum.

Erik B Oleson1, Michael V Beckert, Joshua T Morra, Carien S Lansink, Roger Cachope, Rehab A Abdullah, Amy L Loriaux, Dustin Schetters, Tommy Pattij, Mitchell F Roitman, Aron H Lichtman, Joseph F Cheer.   

Abstract

Transient increases in nucleus accumbens (NAc) dopamine concentration are observed when animals are presented with motivationally salient stimuli and are theorized to energize reward seeking. They arise from high-frequency firing of dopamine neurons in the ventral tegmental area (VTA), which also results in the release of endocannabinoids from dopamine cell bodies. In this context, endocannabinoids are thought to regulate reward seeking by modulating dopamine signaling, although a direct link has never been demonstrated. To test this, we pharmacologically manipulated endocannabinoid neurotransmission in the VTA while measuring transient changes in dopamine concentration in the NAc during reward seeking. Disrupting endocannabinoid signaling dramatically reduced, whereas augmenting levels of the endocannabinoid 2-arachidonoylglycerol (2AG) increased, cue-evoked dopamine concentrations and reward seeking. These data suggest that 2AG in the VTA regulates reward seeking by sculpting ethologically relevant patterns of dopamine release during reward-directed behavior.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284189      PMCID: PMC3269037          DOI: 10.1016/j.neuron.2011.11.018

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  62 in total

1.  Subsecond dopamine release promotes cocaine seeking.

Authors:  Paul E M Phillips; Garret D Stuber; Michael L A V Heien; R Mark Wightman; Regina M Carelli
Journal:  Nature       Date:  2003-04-10       Impact factor: 49.962

2.  Interval timing and the encoding of signal duration by ensembles of cortical and striatal neurons.

Authors:  Matthew S Matell; Warren H Meck; Miguel A L Nicolelis
Journal:  Behav Neurosci       Date:  2003-08       Impact factor: 1.912

3.  Psychoactive drug use in evolutionary perspective.

Authors:  R M Nesse; K C Berridge
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

4.  Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: cellular mechanisms of input selection.

Authors:  S B Floresco; C D Blaha; C R Yang; A G Phillips
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

5.  A cellular mechanism of reward-related learning.

Authors:  J N Reynolds; B I Hyland; J R Wickens
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

6.  The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.

Authors:  M Solinas; L V Panlilio; K Antoniou; L A Pappas; S R Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2003-03-26       Impact factor: 4.030

7.  Patterns of dopamine overflow in mouse nucleus accumbens during intracranial self-stimulation.

Authors:  L Yavich; J Tiihonen
Journal:  Neurosci Lett       Date:  2000-10-20       Impact factor: 3.046

Review 8.  Endocannabinoid signaling in the brain.

Authors:  Rachel I Wilson; Roger A Nicoll
Journal:  Science       Date:  2002-04-26       Impact factor: 47.728

Review 9.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

10.  Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia.

Authors:  M D Julian; A B Martin; B Cuellar; F Rodriguez De Fonseca; M Navarro; R Moratalla; L M Garcia-Segura
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  66 in total

1.  Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.

Authors:  Jason M Wiebelhaus; Travis W Grim; Robert A Owens; Matthew F Lazenka; Laura J Sim-Selley; Rehab A Abdullah; Micah J Niphakis; Robert E Vann; Benjamin F Cravatt; Jenny L Wiley; S Stevens Negus; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2014-11-14       Impact factor: 4.030

2.  Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.

Authors:  Gabriel C Loewinger; Michael V Beckert; Hugo A Tejeda; Joseph F Cheer
Journal:  Neuropharmacology       Date:  2012-01-25       Impact factor: 5.250

3.  κ-Opioid receptors within the nucleus accumbens shell mediate pair bond maintenance.

Authors:  Shanna L Resendez; Morgan Kuhnmuench; Tarin Krzywosinski; Brandon J Aragona
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

4.  Song-associated reward correlates with endocannabinoid-related gene expression in male European starlings (Sturnus vulgaris).

Authors:  Allison H Hahn; Devin P Merullo; Jeremy A Spool; Caroline S Angyal; Sharon A Stevenson; Lauren V Riters
Journal:  Neuroscience       Date:  2017-01-29       Impact factor: 3.590

5.  Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.

Authors:  Dan P Covey; Hannah M Dantrassy; Samantha E Yohn; Alberto Castro; P Jeffrey Conn; Yolanda Mateo; Joseph F Cheer
Journal:  Neuropsychopharmacology       Date:  2018-06-01       Impact factor: 7.853

6.  Cannabinoids and value-based decision making: implications for neurodegenerative disorders.

Authors:  Angela M Lee; Erik B Oleson; Leontien Diergaarde; Joseph F Cheer; Tommy Pattij
Journal:  Basal Ganglia       Date:  2012-07-28

7.  Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.

Authors:  Yolanda Mateo; Kari A Johnson; Dan P Covey; Brady K Atwood; Hui-Ling Wang; Shiliang Zhang; Iness Gildish; Roger Cachope; Luigi Bellocchio; Manuel Guzmán; Marisela Morales; Joseph F Cheer; David M Lovinger
Journal:  Neuron       Date:  2017-12-06       Impact factor: 17.173

Review 8.  A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature.

Authors:  Jennifer M Wenzel; Noah A Rauscher; Joseph F Cheer; Erik B Oleson
Journal:  ACS Chem Neurosci       Date:  2014-12-24       Impact factor: 4.418

Review 9.  Illicit dopamine transients: reconciling actions of abused drugs.

Authors:  Dan P Covey; Mitchell F Roitman; Paul A Garris
Journal:  Trends Neurosci       Date:  2014-03-20       Impact factor: 13.837

10.  Subsecond dopamine release in the nucleus accumbens predicts conditioned punishment and its successful avoidance.

Authors:  Erik B Oleson; Ronny N Gentry; Vivian C Chioma; Joseph F Cheer
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.